Endoscopic cyanoacrylate injection versus β-blocker for secondary prophylaxis of gastric variceal bleed: A randomised controlled trial

Gut

Volumn 59, Issue 6, 2010, Pages 729-735

  Mishra, Smruti Ranjan ^a   Sharma, Barjesh Chander ^a   Kumar, Ashish ^b   Sarin, Shiv Kumar ^a,b  

^a G B PANT HOSPITAL   (India)

^b INSTITUTE OF LIVER AND BILIARY SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CYANOACRYLATE; PROPRANOLOL;

ARTICLE; BACTERIAL PERITONITIS; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DISEASE CLASSIFICATION; DRUG EFFICACY; ENDOSCOPY; FOLLOW UP; HUMAN; MORTALITY; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; STOMACH VARICES; TREATMENT RESPONSE; VENOUS PRESSURE;

ADOLESCENT; ADRENERGIC BETA-ANTAGONISTS; ADULT; AGED; CHILD; CYANOACRYLATES; EMBOLIZATION, THERAPEUTIC; ENDOSCOPY, GASTROINTESTINAL; ESOPHAGEAL AND GASTRIC VARICES; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEPATIC VEINS; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PROPRANOLOL; RECURRENCE; RISK FACTORS; SURVIVAL ANALYSIS; TISSUE ADHESIVES; TREATMENT OUTCOME; VENOUS PRESSURE; YOUNG ADULT;

EID: 77953693154     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gut.2009.192039     Document Type: Article

References (39)

1. Sarin SK, Lahoti D, Saxena SP, et al. Prevalence, classification and natural history of gastric varices: a long-term follow-up study in 568 portal hypertension patients. Hepatology 1992;16:1343-9.
2. Trudeau W, Prindiville T. Endoscopic injection sclerosis in bleeding gastric varices. Gastrointest Endosc 1986;32:264-8. (Pubitemid 16044277)
3. Thakeb F, Salem SA, Abdallah M, et al. Endoscopic diagnosis of gastric varices. Endoscopy 1994;26:287-91.
4. Bretagne JF, Dudicourt JC, Morisot D, et al. Is endoscopic variceal sclerotherapy effective for the treatment of gastric varices? [abstract]. Dig Dis Sci 1986;31:505S.
5. Sarin SK. Long-term follow-up of gastric variceal sclerotherapy: an eleven-year experience. Gastrointest Endosc 1997;46:8-14.
6. Lebrec D. Pharmacological treatment of portal hypertension: hemodynamic effects and prevention of bleeding. Pharmacol Ther 1994;61:65-107.
7. Hayes PC, Davis JM, Lewis JA, et al. Meta-analysis of value of propranolol in prevention of variceal haemorrhage. Lancet 1990;336:153-6.
8. Lin HC, Soubrane O, Lebrec O. Prevention of portal hypertension and portosystemic shunts by early chronic administration of clonidine in conscious portal vein-stenosed rats. Hepatology 1991;14:325-30.
9. Sarin SK, Groszmann RJ, Mosca PG, et al. Propranolol ameliorates the development of portal-systemic shunting in a chronic murine schistosomiasis model of portal hypertension. J Clin Invest 1991;87:1032-6.
10. Ideo G, Bellati G, Fesce E, et al. Nadolol can prevent the first gastrointestinal bleeding in cirrhotics: a prospective, randomized study. Hepatology 1988;8:6-9. (Pubitemid 18092050)
11. The Italian Multicenter Project for Propranolol in Prevention of Bleeding. Propranolol prevents first gastrointestinal bleeding in non-ascitic cirrhotic patients. Final report of a multicenter randomized trial. J Hepatol 1989;9:75-83.
12. Wu CY, Yeh HZ, Chen GH. Pharmacologic efficacy in gastric variceal rebleeding and survival: including multivariate analysis. J Clin Gastroenterol 2002;35:127-32.
13. Lo GH, Lai KH, Cheng JS, et al. A prospective, randomized trial of butyl cyanoacrylate injection versus band ligation in the management of bleeding gastric varices. Hepatology 2001;33:1060-4.
14. Soehendra N, Nam VC, Grimm H, et al. Endoscopic obliteration of large esophagogastric varices with bucrylate. Endoscopy 1986;18:25-6. (Pubitemid 16134957)
15. Ramond MJ, Valla D, Mosnier JF, et al. Successful endoscopic obliteration of gastric varices with butyl cyanoacrylate. Hepatology 1989;10:488-93. (Pubitemid 19255471)
16. Huang YH, Yeh HZ, Chen GH, et al. Endoscopic treatment of bleeding gastric varices by N-butyl-2-cyanoacrylate (Histoacryl) injection: long-term efficacy and safety. Gastrointest Endosc 2000;52:160-7.
17. Binmoeller KF, Soehendra N. "Superglue": the answer to variceal bleeding and fundal varices? Endoscopy 1995;27:392-6.
18. Ryan BM, Stockbrugger RW, Ryan JM. A pathophysiologic, gastroenterologic, and radiologic approach to the management of gastric varices. Gastroenterology 2004;126:1175-89.
19. Sarin SK, Jain AK, Jain M, et al. A randomized controlled trial of cyanoacrylate versus alcohol injection in patients with isolated fundic varices. Am J Gastroenterol 2002;97:1010-15.
20. Akahoshi T, Hashizume M, Shimabukuro R, et al. Long-term results of endoscopic histoacryl injection sclerotherapy for gastric variceal bleeding: a 10-year experience. Surgery 2002;131:S176-81.
21. Kim JW, Baik SK, Kim KH, et al. Effect of endoscopic sclerotherapy using N-butyl-2-cyanoacrylate in patients with gastric variceal bleeding. Korean J Hepatol 2006;12:394-403.
22. de Franchis R. Evolving consensus in portal hypertension report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol 2005;43:167-76.
23. Ramesh J, Limdi JK, Sharma V, et al. The use of thrombin injections in the management of bleeding gastric varices: a single center experience. Gastrointest Endosc 2008;68:877-82.
24. Yang WL, Tripathi D, Therapondos G, et al. Endoscopic use of human thrombin in bleeding gastric varices. Am J Gastroenterol 2002;97:1381-5.
25. Datta D, Vlavianos P, Alisa A, et al. Use of fibrin glue (beriplast) in the management of bleeding gastric varices. Endoscopy 2003;35:675-8.
26. Tripathi D, Hayes PC. Endoscopic therapy for bleeding gastric varices: to clot or glue? Gastrointest Endosc 2008;68:883-6.
27. Wadhawan M, Dubey S, Sharma BC, et al. Hepatic venous pressure gradient in cirrhosis: correlation with the size of varices, bleeding, ascites, and Child's status. Dig Dis Sci 2006;51:2264-9.
28. Evrard S, Dumonceau JM, Delhaye M, et al. Endoscopic histoacryl obliteration vs. propranolol in the prevention of esophagogastric variceal rebleeding: a randomized trial. Endoscopy 2003;35:729-35.
29. Tripathi D, Therapondos G, Jackson E, et al. The role of the transjugular intrahepatic portosystemic stent shunt (TIPSS) in the management of bleeding gastric varices: clinical and haemodynamic correlations. Gut 2002;51:270-4.
30. Watanabe K, Kimura K, Matsutani S, et al. Portal hemodynamics in patients with gastric varices. A study in 230 patients with esophageal and/or gastric varices using portal vein catheterization. Gastroenterology 1988;95:434-40.
31. Matsumoto A, Hamamoto N, Nomura T, et al. Balloon-occluded retrograde transvenous obliteration of high-risk gastric fundal varices. Am J Gastroenterol 1999;94:643-9.
32. Hong CH, Kim HJ, Park JH. Treatment of patients with gastric variceal hemorrhage: endoscopic N-butyl-2-cyanoacrylate injection versus balloon-occluded retrograde transvenous obliteration. J Gastroenterol Hepatol 2009;24:372-8.
33. Lo GH, Liang HL, Chen WC, et al. A prospective, randomized controlled trial of transjugular intrahepatic portosystemic shunt vs. cyanoacrylate injection in the prevention of gastric variceal rebleeding. Endoscopy 2007;39:679-85.
34. Marques P, Maluf-Filho F, Kumar A, et al. Long-term outcomes of acute gastric variceal bleeding in 48 patients following treatment with cyanoacrylate. Dig Dis Sci 2008;53:544-50.
35. Tripathi D, Ferguson JW, Therapondos G, et al. Review article: recent advances in the management of bleeding gastric varices. Aliment Pharmacol Ther 2006;24:1-17.
36. Tan PC, Hou MC, Lin HC, et al. A randomized trial of endoscopic treatment of acute gastric variceal hemorrhage: N-butyl-2-cyanoacrylate injection versus band ligation. Hepatology 2006;43:690-7.
37. Hwang SS, Kim HH, Park SH, et al. N-butyl-2-cyanoacrylate pulmonary embolism after endoscopic injection sclerotherapy for gastric variceal bleeding. J Comput Assist Tomogr 2001;25:16-22.
38. Yoshida H, Onda M, Tajiri T, et al. Endoscopic findings of bleeding esophagogastric varices. Hepatogastroenterology 2002;49:1287-9.
39. Bhasin DK, Sharma BC, Prasad H, et al. Endoscopic removal of sclerotherapy needle from gastric varix after N-butyl-2-cyanoacrylate injection. Gastrointest Endosc 2000;51:497-8. (Pubitemid 30204782)